Publications by authors named "Jahnvi Patel"
Article Synopsis
- A case study discusses a 38-year-old female with clinically amyopathic dermatomyositis (CADM) displaying symptoms like vasculopathic ulcers, mechanic's hands, and interstitial lung disease (ILD).
- *Her diagnosis included normal muscle enzyme levels and the presence of specific antibodies (anti-Mi2 and anti-MDA-5) confirmed through immunoblotting.
- *Following an inadequate response to standard treatments, the addition of tofacitinib, which inhibits the JAK-STAT pathway and type 1 interferon, resulted in significant improvement in her skin and lung condition over six months.
Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of and : a case report from India.
Access Microbiol
October 2023
Introduction: The Lucio phenomenon (LP) is a characteristic reaction pattern seen in patients with diffuse lepromatous leprosy (DLL). Dual infection with and in DLL has been confirmed from other endemic countries but not previously documented from India. Conventionally, LP is treated with a high dose of systemic glucocorticoid (GC) and anti-leprosy treatment (ALT).
View Article and Find Full Text PDFClinical Scenario: Eating disorders (EDs) and disordered eating (DE) result in numerous physical and psychological complications for female and male athletes. Besides bone-related injury, little research exists investigating what injuries EDs and/or DE contribute to.
Clinical Question: Are EDs and/or DE a risk factor for injury incidence in athletes?
Summary Of Key Findings: We searched for prospective studies assessing EDs or DE as a risk factor for injury in female or male athletes high school age and older.